EchoGo® Heart Failure vs Acumen Hypotension Prediction Index (HPI) Feature Software
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is designed for the AI-powered diagnosis of Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing echocardiograms. In contrast, Tool B, Acumen Hypotension Prediction Index (HPI) Feature Software, focuses on predicting acute hypotensive events using machine learning on hemodynamic monitoring data. While both are AI tools applicable in cardiology and emergency medicine, they address distinct clinical problems: one is diagnostic for a chronic condition, and the other is predictive for an acute physiological event.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform designed to analyze routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF). Acumen Hypotension Prediction Index (HPI) Feature Software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips to provide insights. Acumen HPI software uses machine learning algorithms to analyze blood pressure waveforms, compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring.
EchoGou00ae Heart Failure delivers insights from echocardiogram analysis within 20 minutes. Acumen HPI software predicts hypotension up to 15 minutes before an event, with the HPI parameter updating every 20 seconds.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For Acumen HPI, pricing details are not publicly available, and interested parties need to contact Edwards Lifesciences directly for information.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection, and was trained on over 10 years of outcome data. Acumen HPI software has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension.
EchoGou00ae Heart Failure is primarily targeted towards Cardiology, Emergency Medicine, and Internal Medicine specialties for HFpEF detection. Acumen HPI software is designed for Anesthesiology, Critical Care, and Emergency Medicine, focusing on hemodynamic management.